drugset / Trial / NCT01652339
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects
RandomizedCrossoverOpen-label
Summary
To assess the pharmacokinetic characteristics of Lodivixx tab.5/160mg in healthy male subjects * PK parameter evaluation * Safety profile evaluation
Timeline
- Start
- 2012-07
- Primary completion
- 2012-08
- Completion
- 2012-12
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amlodipine | Other / unclassified | 10 mg | — |
| Subject | S-amlodipine | Unknown | 5 mg | — |
| Comparator | Valsartan | Small molecule | 160 mg | — |
Indications
No indication recorded.